Liza Noonan, chief executive of Sydney-based Cicada Innovations, stated that the country's natural resources, vast landscape, proximity to Asia, and sophisticated clinical trial environment make it an "attractive proposition" for deep tech to thrive and bolster its sovereign capabilities across industries.